Education
About Us
Working with TipRanks
Follow Us
Bliss Gvs Pharma Limited (IN:BLISSGVS)
:BLISSGVS
BLISSGVS Stock Chart & Stats
₹144.75
-₹6.85(-3.92%)
At close: 4:00 PM EST
₹144.75
-₹6.85(-3.92%)
Day’s Range― - ―
52-Week Range₹105.05 - ₹190.65
Previous CloseN/A
Volume571.01K
Average Volume (3M)104.36K
Market Cap
₹15.30B
Enterprise Value₹15.27B
Total Cash (Recent Filing)₹1.41B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)13.9
Beta1.78
Next Earnings
Jan 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.35%
Share Statistics
EPS (TTM)2.58
Shares Outstanding105,722,595
10 Day Avg. Volume77,644
30 Day Avg. Volume104,358
Financial Highlights & Ratios
PEG Ratio1.37
Price to Book (P/B)1.20
Price to Sales (P/S)1.56
P/FCF Ratio42.37
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bliss Gvs Pharma Limited News
BLISSGVS FAQ
What was Bliss Gvs Pharma Limited’s price range in the past 12 months?
Bliss Gvs Pharma Limited lowest stock price was ₹105.05 and its highest was ₹190.65 in the past 12 months.
What is Bliss Gvs Pharma Limited’s market cap?
Bliss Gvs Pharma Limited’s market cap is ₹15.30B.
When is Bliss Gvs Pharma Limited’s upcoming earnings report date?
Bliss Gvs Pharma Limited’s upcoming earnings report date is Jan 27, 2026 which is in 39 days.
How were Bliss Gvs Pharma Limited’s earnings last quarter?
Bliss Gvs Pharma Limited released its earnings results on Nov 06, 2025. The company reported ₹2.58 earnings per share for the quarter, beating the consensus estimate of N/A by ₹2.58.
Is Bliss Gvs Pharma Limited overvalued?
According to Wall Street analysts Bliss Gvs Pharma Limited’s price is currently Overvalued.
Does Bliss Gvs Pharma Limited pay dividends?
Bliss Gvs Pharma Limited pays a Annually dividend of ₹0.5 which represents an annual dividend yield of 0.35%. See more information on Bliss Gvs Pharma Limited dividends here
What is Bliss Gvs Pharma Limited’s EPS estimate?
Bliss Gvs Pharma Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bliss Gvs Pharma Limited have?
Bliss Gvs Pharma Limited has 105,722,595 shares outstanding.
What happened to Bliss Gvs Pharma Limited’s price movement after its last earnings report?
Bliss Gvs Pharma Limited reported an EPS of ₹2.58 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.267%.
Which hedge fund is a major shareholder of Bliss Gvs Pharma Limited?
Currently, no hedge funds are holding shares in IN:BLISSGVS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Bliss Gvs Pharma Limited
Bliss Gvs Pharma Limited (BLISSGVS) is a leading pharmaceutical company based in India, specializing in the development and manufacturing of a wide range of pharmaceutical products, including formulations, active pharmaceutical ingredients (APIs), and over-the-counter (OTC) medications. The company primarily operates in the sectors of generic pharmaceuticals and specialty formulations, catering to both domestic and international markets. With a focus on quality and innovation, Bliss Gvs Pharma is dedicated to providing affordable healthcare solutions across various therapeutic areas.
Technical Analysis
Bajaj Healthcare Ltd
―
Hester Biosciences Limited
―
Jagsonpal Pharmaceuticals Ltd.
―
Syncom Formulation (India) Ltd.
―
Windlas Biotech Ltd.
―